Fausto Rossini

2.5k total citations
44 papers, 700 citations indexed

About

Fausto Rossini is a scholar working on Oncology, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, Fausto Rossini has authored 44 papers receiving a total of 700 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 19 papers in Hematology and 9 papers in Pathology and Forensic Medicine. Recurrent topics in Fausto Rossini's work include Multiple Myeloma Research and Treatments (13 papers), Lymphoma Diagnosis and Treatment (9 papers) and Cancer Treatment and Pharmacology (8 papers). Fausto Rossini is often cited by papers focused on Multiple Myeloma Research and Treatments (13 papers), Lymphoma Diagnosis and Treatment (9 papers) and Cancer Treatment and Pharmacology (8 papers). Fausto Rossini collaborates with scholars based in Italy, Spain and Chile. Fausto Rossini's co-authors include Enrico Maria Pogliani, Sandro Barni, Pietro Pioltelli, Pellegrino Musto, Gabriele Tancini, Mario Boccadoro, Paolo Lissoni, Francesca Gay, Sandro Sironi and Davide Ippolito and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Fausto Rossini

43 papers receiving 663 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fausto Rossini Italy 15 378 339 230 89 87 44 700
Jude Abadie United States 13 410 1.1× 156 0.5× 349 1.5× 123 1.4× 45 0.5× 28 784
Nada Starčević Čizmarević Croatia 14 120 0.3× 65 0.2× 120 0.5× 78 0.9× 99 1.1× 37 539
Bodil Petersen Germany 9 163 0.4× 97 0.3× 82 0.4× 45 0.5× 75 0.9× 18 523
Limin Liu China 11 160 0.4× 93 0.3× 118 0.5× 55 0.6× 14 0.2× 53 593
Kenji Sakakibara Japan 17 87 0.2× 79 0.2× 257 1.1× 42 0.5× 22 0.3× 51 771
R K Desai United States 14 68 0.2× 42 0.1× 168 0.7× 24 0.3× 74 0.9× 29 688
Charles Mahler Belgium 13 42 0.1× 65 0.2× 137 0.6× 105 1.2× 63 0.7× 21 1.1k
B Fisher United Kingdom 10 64 0.2× 52 0.2× 98 0.4× 49 0.6× 32 0.4× 18 688
Yasunori Matsuki Japan 15 94 0.2× 44 0.1× 122 0.5× 28 0.3× 40 0.5× 40 662
Arnold C. Koekman Netherlands 12 165 0.4× 34 0.1× 113 0.5× 119 1.3× 41 0.5× 20 501

Countries citing papers authored by Fausto Rossini

Since Specialization
Citations

This map shows the geographic impact of Fausto Rossini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fausto Rossini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fausto Rossini more than expected).

Fields of papers citing papers by Fausto Rossini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fausto Rossini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fausto Rossini. The network helps show where Fausto Rossini may publish in the future.

Co-authorship network of co-authors of Fausto Rossini

This figure shows the co-authorship network connecting the top 25 collaborators of Fausto Rossini. A scholar is included among the top collaborators of Fausto Rossini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fausto Rossini. Fausto Rossini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mangiacavalli, Silvia, Sara Pezzatti, Fausto Rossini, et al.. (2016). Implemented myeloma management with whole-body low-dose CT scan: a real life experience. Leukemia & lymphoma. 57(7). 1539–1545. 10 indexed citations
2.
Ippolito, Davide, et al.. (2013). Diagnostic value of whole-body low-dose computed tomography (WBLDCT) in bone lesions detection in patients with multiple myeloma (MM). European Journal of Radiology. 82(12). 2322–2327. 52 indexed citations
3.
Mian, Michael, Andrés J.M. Ferreri, Andrea Rossi, et al.. (2012). Role of radiotherapy in patients with early-stage diffuse large B-cell lymphoma of Waldeyer's ring in remission after anthracycline-containing chemotherapy. Leukemia & lymphoma. 54(1). 62–68. 11 indexed citations
4.
Corso, Alessandro, Mónica Galli, Silvia Mangiacavalli, et al.. (2011). Response‐adjusted ISS (RaISS) is a simple and reliable prognostic scoring system for predicting progression‐free survival in transplanted patients with multiple myeloma. American Journal of Hematology. 87(2). 150–154. 8 indexed citations
5.
6.
Palumbo, Antonio, Francesca Gay, Patrizia Falco, et al.. (2010). Bortezomib As Induction Before Autologous Transplantation, Followed by Lenalidomide As Consolidation-Maintenance in Untreated Multiple Myeloma Patients. Journal of Clinical Oncology. 28(5). 800–807. 114 indexed citations
7.
Lanzani, Francesca, Laura Mattavelli, Barbara Frigeni, et al.. (2008). Role of a pre‐existing neuropathy on the course of bortezomib‐induced peripheral neurotoxicity. Journal of the Peripheral Nervous System. 13(4). 267–274. 46 indexed citations
8.
Musto, Pellegrino, Fausto Rossini, Francesca Gay, et al.. (2007). Efficacy and safety of bortezomib in patients with plasma cell leukemia. Cancer. 109(11). 2285–2290. 46 indexed citations
9.
Musto, Pellegrino, Potito Rosario Scalzulli, Elisabetta Terruzzi, et al.. (2007). Peg-filgrastim versus filgrastim after autologous stem cell tranplantation: Case-control study in patients with multiple myeloma and review of the literature. Leukemia Research. 31(11). 1487–1493. 11 indexed citations
10.
Rossini, Fausto, Elisabetta Terruzzi, Simona Cammarota, et al.. (2005). Cytomegalovirus infection after autologous stem cell transplantation: incidence and outcome in a group of patients undergoing a surveillance program. Transplant Infectious Disease. 7(3-4). 122–125. 28 indexed citations
11.
12.
Rossini, Fausto, Elisabetta Terruzzi, Luisa Verga, et al.. (2004). A randomized clinical trial of ceftriaxone and amikacin versus piperacillin tazobactam and amikacin in febrile patients with hematological neoplasia and severe neutropenia. Supportive Care in Cancer. 13(6). 387–392. 12 indexed citations
13.
Bringhen, Sara, Alessandra Bertola, Federica Cavallo, et al.. (2003). TWO DOSE-INTENIVE MELPHALAN REGIMENS (100 MG/M2 VERSUS 200 MG/M2) IN MULTIPLE MYELOMA PATIENTS. Haematologica. 88. 17–18. 12 indexed citations
14.
Rossini, Fausto, Pietro Pioltelli, Silvia Bolis, et al.. (1998). Ceftriaxone/Amikacin vs Ceftazidime/Amikacin as Empirical Therapy for Fever in Patients with Haematological Malignancy and Severe Granulocytopenia. Clinical Drug Investigation. 15(5). 425–433. 4 indexed citations
15.
Pogliani, Enrico Maria, et al.. (1997). Thrombotic Complications in Acute Promyelocytic Leukemia during All-trans-Retinoic Acid Therapy. Acta Haematologica. 97(4). 228–230. 18 indexed citations
16.
̃Tassi, E., et al.. (1996). Alpha interferon as initial treatment of essential thrombocythemia. Analysis after two years of follow-up.. PubMed. 81(4). 245–8. 2 indexed citations
17.
Rossini, Fausto. (1996). Prognosis of infections in elderly patients with haematological diseases. Supportive Care in Cancer. 4(1). 46–50. 8 indexed citations
18.
Lissoni, Paolo, Sandro Barni, Fernando Brivio, et al.. (1995). A Biological Study on the Efficacy of Low–Dose Subcutaneous lnterleukin–2 plus Melatonin in the Treatment of Cancer–Related Thrombocytopenia. Oncology. 52(5). 360–362. 26 indexed citations
19.
Rossini, Fausto, et al.. (1994). Amikacin and ceftazidime as empirical antibiotic therapy in severely neutropenic patients: analysis of prognostic factors. Supportive Care in Cancer. 2(4). 259–265. 10 indexed citations
20.
Rossini, Fausto, et al.. (1991). Non-Hodgkin's lymphoma of the elderly. Prognostic factors and outcome.. PubMed. 82(5). 262–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jude Abadie Breakdown of academic impact, for papers by Nada Starčević Čizmarević Breakdown of academic impact, for papers by Bodil Petersen Breakdown of academic impact, for papers by Limin Liu Breakdown of academic impact, for papers by Kenji Sakakibara Breakdown of academic impact, for papers by R K Desai Breakdown of academic impact, for papers by Charles Mahler Breakdown of academic impact, for papers by B Fisher Breakdown of academic impact, for papers by Yasunori Matsuki Breakdown of academic impact, for papers by Arnold C. Koekman
Rankless by CCL
2026